Targeting oxidant-dependent mechanisms that drive COPD and its co-morbidities

慢性阻塞性肺疾病（COPD）是一种肺部疾病，是全球第四大死亡原因。目前还没有有效的治疗方法来治疗COPD患者，每年花费澳大利亚社区超过88亿澳元。COPD的大部分疾病负担和医疗保健费用与其合并症（即其他慢性疾病，如心脏病）的管理有关。该项目将开发治疗COPD及其合并症的新疗法。

Chronic obstructive pulmonary disease (COPD) is a lung disease that is the 4th leading cause of death worldwide. There is currently no effective therapy to treat people with COPD, which costs the Australian community over $8.8 billion/year. Much of the disease burden and health care costs in COPD is associated with the management of its comorbidities (i.e other chronic medical conditions such as heart disease). This project will develop novel therapies to treat COPD and its comorbidities.